Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Me Group delivers 'record' H1 profitability

(Sharecast News) - Instant-service equipment business Me Group told investors on Monday that it had delivered record profitability in the six months ended 30 April and said it was on track to deliver FY25 profits in line with expectations for another record year. Me Group said total pre-tax profits were up approximately 14%, while group revenues were roughly 2% firmer, driven by a "strong" performance in its Revolution laundry division. Excluding the H124 contribution from SEMPA SAS, which was sold in May 2024, interim revenues grew approximately 3.5% year-on-year.

Laundry operations saw revenues grow 13.3%, reflecting ongoing demand across all of its geographies, while photobooth revenue was down approximately 3.3%, primarily due to a technical issue with new printers, which has now been resolved but caused an estimated 2% drop in photobooth revenue in H125.

Me Group stated it has "predictable revenue streams", was "highly cash generative" and has a "strong" balance sheet. At 30 April, net cash was up 69.1% to £36.2m.

"We are pleased to report further progress and profit growth in H125, despite a backdrop of challenging global markets. Whilst the photobooth revenue performance was slightly lower than expected due to the supplier issue referenced above, laundry operations continue to deliver significant growth. Historically, the group's performance is second-half weighted, and the board continues to anticipate FY25 profit before tax will be between £76.0m and £80.0m.

As of 0735 BST, Me Group shares were untraded at 216.62p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.